Author
Listed:
- Ana Rita Carlos
(Telomere and Genome Stability Group, The CR-UK/MRC Gray Institute for Radiation Oncology and Biology
Present address: Instituto Gulbenkian de Ciência, Rua da Quinta Grande 6, Oeiras 2780-156, Portugal)
- Jose Miguel Escandell
(Telomere and Genome Stability Group, The CR-UK/MRC Gray Institute for Radiation Oncology and Biology
Present address: Instituto Gulbenkian de Ciência, Rua da Quinta Grande 6, Oeiras 2780-156, Portugal)
- Panagiotis Kotsantis
(Telomere and Genome Stability Group, The CR-UK/MRC Gray Institute for Radiation Oncology and Biology
Present address: School of Cancer Sciences, University of Birmingham, Edgbaston, Birmingham B15 2TT, UK)
- Natsuko Suwaki
(Telomere and Genome Stability Group, The CR-UK/MRC Gray Institute for Radiation Oncology and Biology
Present address: GlaxoSmithKline, RD Chief Regulatory Office Stockley Park West, 1-3 Ironbridge Road, Middlesex, UB11 1BS, UK)
- Peter Bouwman
(The Netherlands Cancer Institute)
- Sophie Badie
(Telomere and Genome Stability Group, The CR-UK/MRC Gray Institute for Radiation Oncology and Biology)
- Cecilia Folio
(Telomere and Genome Stability Group, The CR-UK/MRC Gray Institute for Radiation Oncology and Biology)
- Javier Benitez
(Human Cancer Genetics Program, Spanish National Cancer Center (CNIO))
- Gonzalo Gomez-Lopez
(Structural Biology and BioComputing Programme, Spanish National Cancer Center (CNIO))
- David G. Pisano
(Structural Biology and BioComputing Programme, Spanish National Cancer Center (CNIO))
- Jos Jonkers
(The Netherlands Cancer Institute)
- Madalena Tarsounas
(Telomere and Genome Stability Group, The CR-UK/MRC Gray Institute for Radiation Oncology and Biology)
Abstract
ARF is a tumour suppressor activated by oncogenic stress, which stabilizes p53. Although p53 is a key component of the response to DNA damage, a similar function for ARF has not been ascribed. Here we show that primary mouse and human cells lacking the tumour suppressor BRCA2 accumulate DNA damage, which triggers checkpoint signalling and ARF activation. Furthermore, senescence induced by Brca2 deletion in primary mouse and human cells is reversed by the loss of ARF, a phenotype recapitulated in cells lacking RAD51. Surprisingly, ARF is not necessary for p53 accumulation per se but for altering the spectrum of genes activated by this transcription factor. Specifically, ARF enables p53 transcription of Dusp4 and Dusp7, which encode a pair of phosphatases known to inactivate the MAP kinases ERK1/2. Our results ascribe a previously unanticipated function to the ARF tumour suppressor in genome integrity, controlled by replicative stress and ATM/ATR-dependent checkpoint responses.
Suggested Citation
Ana Rita Carlos & Jose Miguel Escandell & Panagiotis Kotsantis & Natsuko Suwaki & Peter Bouwman & Sophie Badie & Cecilia Folio & Javier Benitez & Gonzalo Gomez-Lopez & David G. Pisano & Jos Jonkers & , 2013.
"ARF triggers senescence in Brca2-deficient cells by altering the spectrum of p53 transcriptional targets,"
Nature Communications, Nature, vol. 4(1), pages 1-14, December.
Handle:
RePEc:nat:natcom:v:4:y:2013:i:1:d:10.1038_ncomms3697
DOI: 10.1038/ncomms3697
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:4:y:2013:i:1:d:10.1038_ncomms3697. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.